41,926 Shares in Danaher Corporation $DHR Purchased by M.D. Sass LLC

M.D. Sass LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 41,926 shares of the conglomerate’s stock, valued at approximately $7,986,000. Danaher comprises about 0.5% of M.D. Sass LLC’s holdings, making the stock its 27th biggest position.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Main Street Group LTD bought a new stake in shares of Danaher during the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher in the second quarter worth approximately $25,000. JPL Wealth Management LLC bought a new position in Danaher in the third quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the 4th quarter worth $26,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter valued at about $26,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Royal Bank Of Canada upped their target price on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Price Performance

Shares of NYSE DHR opened at $199.62 on Wednesday. The firm has a market capitalization of $140.33 billion, a P/E ratio of 35.46, a PEG ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company’s fifty day moving average is $193.74 and its two-hundred day moving average is $192.50.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the firm posted $0.77 EPS. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.